Do GLP-1 Medications Cause Hair Loss, Cancer, or Fatigue?
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
The research so far does not show that GLP-1 medications cause cancer, the hair loss some people notice is almost always tied to rapid weight loss instead of the drug itself, and fatigue is a known side effect that tends to be mild and temporary.
If you are seeing more hair in your brush, feeling wiped out in the afternoon, or losing sleep over the latest scary headline about Ozempic or Wegovy, you are not imagining things and you are not alone. A lot of people on GLP-1 medications ask these exact questions, and many of them are seeing real changes in their body. The good news is that most of what people worry about turns out to be temporary, manageable, or not backed up by the large studies done so far. This post walks through each concern calmly, shows you what the research actually found, and helps you figure out what is worth paying attention to and what is mostly noise.
Who This Helps
This is for you if you are taking Ozempic, Wegovy, Mounjaro, Zepbound, or the Wegovy pill, or if you are thinking about starting one and you want a clear-eyed look at what the studies actually show. It is also for family members and caregivers who want to help someone weigh the real risks against the internet version of the risks.
A Quick Note on What GLP-1 Medications Are
A GLP-1 receptor agonist, which is the medical term for a medication that activates a receptor in your body that helps with blood sugar and appetite, is a group of medicines that includes semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). For the rest of this post we will just call them GLP-1 medications. They are approved by the FDA for type 2 diabetes, weight management, and in some cases to lower the risk of heart problems (Ozempic Prescribing Information).
Hair Loss on GLP-1 Medications
Does Ozempic or Wegovy Cause Hair Loss?
Yes, some people do notice more shedding, and the studies back up that experience. A 2026 cohort study in JAAD International looked at a large database of patient health records and found higher rates of new-onset hair loss in people taking semaglutide and tirzepatide than in similar people who were not (Vidal, Akiska et al., JAAD International 2026).
A 2025 study that looked at patient-reported side effects sent to the FDA also found that people on Ozempic, Wegovy, Mounjaro, and Zepbound were reporting hair loss at a higher rate than you would expect from most medications (Godfrey et al., JEADV 2025).
Why Hair Loss on GLP-1 Medications Is Probably Happening
Most hair doctors think this kind of shedding is a condition called telogen effluvium, which is a temporary kind of hair loss that shows up after any major body stress. That can be illness, surgery, pregnancy, a crash diet, or losing a lot of weight in a short period of time (Cleveland Clinic, Telogen Effluvium). When you drop weight quickly, your body reads it as a stress event. More of your hairs move into the resting and shedding phase at the same time, and a few months later, you notice extra hair in your brush or on your pillow.
The same thing happens after weight loss surgery, which also causes fast weight loss. A systematic review and meta-analysis of 18 studies covering over 2,500 patients found a pooled incidence of hair loss after metabolic and bariatric surgery of about 57 percent, showing how common shedding is whenever weight drops quickly (Zhang et al., Obesity Surgery systematic review and meta-analysis). That pattern points to how fast the body is changing, rather than to the medication being the main cause.
What the Wegovy Label Says About Hair Loss
Hair loss is listed as a common side effect in the Wegovy prescribing information. In the studies that led to approval, about 3% of people on Wegovy reported hair loss compared with about 1% on a placebo pill (Wegovy Prescribing Information). Hair loss does not appear in the FDA boxed warning. It is listed among the regular side effects, which tells you the FDA does not consider it a serious safety concern.
What This Means for You
If you are noticing extra shedding a few months into treatment, it is most likely this temporary kind of hair loss, and it is most likely going to get better on its own. In most people, the shedding slows once weight stabilizes, and the hair grows back over the next 6 to 12 months. If the shedding is severe, shows up in patches, or you see changes at the scalp or eyebrows, let your doctor know. That pattern can point to other causes like thyroid issues, low iron, or a protein gap that are worth checking separately.
Cancer Risk on GLP-1 Medications
Do GLP-1 Medications Cause Thyroid Cancer?
This is the cancer question people worry about the most. Every GLP-1 medication approved for weight loss or type 2 diabetes, including Ozempic, Wegovy, Mounjaro, and Zepbound, carries a boxed warning about a rare kind of thyroid cancer called medullary thyroid carcinoma, or MTC for short (Wegovy Prescribing Information). The warning is based on studies where rats and mice given GLP-1 medications developed thyroid tumors.
The important thing to know is what has been found in people. In a 2025 study that followed more than 460,000 patients on GLP-1 medications and compared them with millions of patients on other diabetes drugs, researchers found no extra thyroid cancer risk in the GLP-1 group (Morales et al., Diabetes Care 2025).
A large study in Scandinavia, published in BMJ, did not find an overall increase in thyroid cancer with GLP-1 medications. The number for MTC specifically was a touch above the comparison group, but the MTC cases were so rare that the researchers could not tell if that small difference was real or just chance (Pasternak et al., BMJ 2024).
In 2026, researchers pulled together the results of 48 clinical trials covering about 94,000 people. Thyroid cancer showed up at about the same rate in people on GLP-1 medications as in people who were not. The authors concluded that GLP-1 medications probably have little or no effect on thyroid cancer risk (Ko et al., Annals of Internal Medicine 2026).
If that sounds like a lot to take in, here is the plain version. Rats got thyroid tumors. People, so far, do not appear to be getting them at a higher rate. The FDA keeps the warning in place because it wants longer-term human data before removing it, which is standard for any warning based on animal studies.
Do Ozempic or Wegovy Cause Pancreatic Cancer?
Pancreatic cancer comes up often because GLP-1 medications can cause inflammation of the pancreas (called pancreatitis) in rare cases, and because people sometimes mix up pancreatitis with pancreatic cancer. They are two different things. The same 2026 review of 48 clinical trials found no meaningful link between GLP-1 medications and pancreatic cancer (Ko et al., Annals of Internal Medicine 2026).
A 2025 real-world study that looked at millions of patient records and was published in the Journal of the National Cancer Institute actually found lower pancreatic cancer rates in people on GLP-1 medications compared with people on other diabetes drugs (Wang et al., JNCI 2025).
What the Boxed Warning Really Means for You
The boxed warning on the Wegovy, Ozempic, Mounjaro, and Zepbound labels says people with a personal or family history of medullary thyroid cancer, or a rare genetic syndrome called Multiple Endocrine Neoplasia type 2 (MEN 2), should not take these medications (Wegovy Prescribing Information). If that family history does not apply to you, the best evidence available today does not point to a cancer risk that should keep you up at night.
What This Means for You
Before you start a GLP-1 medication, your prescriber should ask about your family history of medullary thyroid cancer and MEN 2. If either one is in the family, you will likely be steered toward a different option. If not, you can move forward with the comfort that the largest human studies to date have not found a real cancer signal, and researchers are still watching.
Fatigue on GLP-1 Medications
Why Do I Feel Tired on Ozempic, Wegovy, or Zepbound?
Fatigue is listed as a side effect in the prescribing information for both Wegovy and Zepbound. In the studies behind Wegovy, about 11% of people reported fatigue compared with about 5% on a placebo (Wegovy Prescribing Information). In the studies behind Zepbound, about 5% of people reported fatigue (Zepbound Prescribing Information).
There are a few reasons you might feel tired. You are eating less, so your daily calories drop, which can leave you short on energy if you are not watching protein and hydration (Harvard T.H. Chan School of Public Health, Protein). Nausea, which is common in the first few weeks, can make food unappealing and make the calorie gap bigger. Dehydration from vomiting or just drinking less can add to the tiredness. And losing weight quickly in general is known to pull energy levels down for a while (Mayo Clinic Press, safe and effective use of prescription weight-loss medications).
What Helps With GLP-1 Fatigue
If that sounds like a lot, remember that most patients describe the fatigue as mild, and it usually eases as the body adjusts or the dose is changed. A few simple habits go a long way:
- Protein at every meal. Many people on GLP-1 medications aim for roughly 25 to 30 grams per meal to keep energy steady.
- Water on a schedule. Sip through the day, not just when thirsty, since thirst cues can be quieter on these medications.
- Consistent sleep. Rapid weight loss is easier on the body with a steady bedtime and wake time.
- A check for the usual suspects. Low iron, low vitamin B12, or a thyroid issue can all show up during fast weight loss and can look like fatigue. Your doctor can run a quick blood test to rule them out.
Language to Watch For
When you are scrolling through headlines or social posts about GLP-1 side effects, a few phrases show up over and over that are worth looking at more carefully.
- “Ozempic causes cancer.” This claim usually traces back to the rodent studies that led to the boxed warning, not to human outcomes. The large human studies done since then have not found an increased cancer risk.
- “GLP-1s are causing an epidemic of hair loss.” Shedding is more common on GLP-1 medications than on placebo, but the pattern matches what doctors see after any fast weight loss, and it is usually temporary.
- “The FDA is about to pull these drugs off the market.” The FDA has not signaled that it plans to pull GLP-1 medications. It has taken action against misleading marketing of compounded versions, which is about advertising claims, not about the medications themselves.
- “These side effects are hidden.” Hair loss and fatigue are both listed in the prescribing information that every pharmacist and doctor can pull up. They are not secret.
What About Compounded GLP-1 Medications?
Most of the research above was done on FDA-approved brand medications like Ozempic, Wegovy, Mounjaro, and Zepbound. If you are taking a GLP-1 compound from a licensed 503A or 503B compounding pharmacy, your medication is prepared within established regulatory rules and is a legitimate option your doctor and pharmacist can walk you through (GLP Winner: 503A vs 503B pharmacies). Compounded GLP-1 medications are not FDA-approved as finished drugs, and they have not been studied in the same large clinical trials, so your best move is to ask your pharmacy about their credentials, their sourcing, and their dosing protocol. Grey-market sellers that operate outside of licensed pharmacy channels are a separate issue and carry risks that licensed compounded products do not.
What Should You Do If You Have Concerns?
A few steady steps can make a real difference if you are worried about any of these side effects.
- Ask your prescriber about your family history of medullary thyroid cancer or MEN 2 before starting treatment. This is a standard screening step.
- Track your protein, water, and sleep. Aim for protein at every meal, water throughout the day, and a regular sleep schedule. This covers most of the common fatigue complaints.
- Pay attention to how fast you are losing weight. A steady pace is easier on your hair, your muscle mass, and your energy than a fast drop.
- Tell your doctor about any new or ongoing side effects. Hair loss that lasts past a year, severe fatigue, a hard lump in the neck, or ongoing stomach pain are all worth a closer look.
- If your pharmacy is a compounding pharmacy, ask about its 503A or 503B status, its dosing protocol, and how your dose is tracked.
Final Takeaway
The headlines about GLP-1 side effects can feel a lot louder than the research behind them. When you line the studies up, the picture is calmer than the internet makes it seem.
Hair shedding is real for some people, but it is usually tied to how fast you are losing weight, and it usually grows back. Cancer risk has been studied in very large groups of patients, and the results so far do not point to a real increase. Fatigue is a known side effect, it is usually mild, and it tends to ease with better hydration, more protein, and dose adjustments.
If you are weighing whether a GLP-1 medication is right for you, you do not have to make that call from a place of fear. You can make it from a place of information. Your prescriber is the right partner for the details of your medical history, and a transparent comparison of providers and pricing can help with the practical side.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Learn which risks are real, which are exaggerated, and what most people actually experience over time.
Worried about GLP-1 side effects like stomach paralysis or “Ozempic face”? This guide debunks myths with real research and clear answers.
Worried about GLP-1 side effects? Learn what’s common, how often it happens, and when symptoms usually start.
Certain foods can worsen nausea, bloating, and reflux on GLP-1 medications. Learn which foods often trigger symptoms and which tend to help.
Curated by
